COVAXIN
COVID-19 Vaccine Update: Phase-3 Trial of Bharat Biotech's Covaxin Begins at Sola Civil Hospital in Ahmedabad
COVID-19 Vaccine Covaxin's Phase-3 Trials to Start in Sola Civil Hospital in Ahmedabad, Says Gujarat Deputy CM Nitin Patel
Coronavirus Vaccine Covaxin Will Be at Least 60% Effective, Higher Than Criteria Set by WHO: Bharat Biotech
Covaxin Volunteer Showed Adverse Effect During Phase 1 Trials, Says Report; Bharat Biotech Claims Illness 'Unrelated' to Vaccine
Anil Vij, Haryana Minister Gets Trial Dose Of COVID-19 Vaccine Covaxin; Union Health Minister On India's Vaccine Distribution Plan; Oxford Vaccine Likely By April 2021, Rs 1,000 For 2 Doses: Adar Poonawalla
Anil Vij Gets Trial Dose of Covaxin at Hospital in Ambala as Bharat Biotech Kicks Off Phase 3 Trials in Haryana; Watch Video
COVID-19 Vaccine in India Update: Vaccinating 130 Crore People With Injectable Covaxin a Challenge, Says Bharat Biotech
COVID-19 Vaccine Development: Major Updates on Oxford-AstraZeneca, Bharat Biotech & Sinopharm Candidates
Coronavirus Vaccine Covaxin, Developed by Bharat Biotech, Likely to be Launched in Second Quarter of Year 2021
COVID-19 Vaccine in India: Prioritisation Has to Be Done on Criteria for Vaccination, Says Dr VK Paul
COVID-19 Vaccine Update: Johnson & Johnson Says Vaccine Could Be Available from January 2021; AstraZeneca Produces Robust Immune Response
COVID-19 Vaccine: Bharat Biotech to Conduct Phase-3 Trials of Covaxin in 26,000 Volunteers
COVID-19 Vaccine: Apollo Hospitals Ready to Administer One Million Coronavirus Vaccines Daily
When Will India Get COVID-19 Vaccine? Here's Where AstraZeneca, Sputnik V And Other Vaccine Trials Stand in India
Google Trends